The Medical Letter on Drugs and Therapeutics
FROM
ISSUE1103
ISSUE1103
April 30, 2001
Bivalirudin (Angiomax) For Angioplasty
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
Bivalirudin (Angiomax) For Angioplasty
April 30, 2001 (Issue: 1103)
Bivalirudin is being promoted as an intravenous (IV) anticoagulant that can be used instead of heparin in patients with unstable angina undergoing coronary angioplasty.
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.